Literature DB >> 5335833

Coombs' positive reactions associated with sodium cephalothin therapy.

H R Gralnick, L D Wright, M H McGinniss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5335833

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Positive direct Coombs' test without hemolytic anemia, attributed to penicillin therapy.

Authors:  R B Roy; L Doris; D S Beanlands
Journal:  Can Med Assoc J       Date:  1968-08-17       Impact factor: 8.262

2.  Immunohaematological cross-allergenicity between penicillin and cephalothin in humans.

Authors:  G N Abraham; L D Petz; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1968-05       Impact factor: 4.330

3.  Use and control of cephalosporins.

Authors:  S Eykyn
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

4.  [Incidence and mechanism of a positive direct antiglobulin (Coombs') test in cephalosporin treatment (author's transl)].

Authors:  P Spath; G Garratty; L D Petz
Journal:  Klin Wochenschr       Date:  1973-05-01

5.  Acute intravascular haemolysis associated with cephalexin therapy.

Authors:  C D Forbes; J A Craig; R Mitchell; G P McNicol
Journal:  Postgrad Med J       Date:  1972-03       Impact factor: 2.401

6.  Red cell metabolism in positive direct Coombs test after cephalothin therapy.

Authors:  S Ferrone; A Zanella; M Scalamogna
Journal:  Experientia       Date:  1971-02-15

7.  Cephalothin-treated normal red cells: a new type of PNH-like cells.

Authors:  G Sirchia; F Mercuriali; S Ferrone
Journal:  Experientia       Date:  1968-05-15

8.  Penicillin-induced haemolytic anaemia.

Authors: 
Journal:  Br Med J       Date:  1968-07-06

9.  Cephalothin positive direct Coombs test. Relationship to serum immunoglobulin concentration.

Authors:  S Ferrone; F Mercuriale; M Scalamogna
Journal:  Experientia       Date:  1971-02-15

10.  Lysosomes in disease.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1967-12       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.